Literature DB >> 22549384

Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.

Chen Sabrina Tan1, Evelyn Bord, Thomas A Broge, Brett Glotzbecker, Heidi Mills, Sarah Gheuens, Jacalyn Rosenblatt, David Avigan, Igor J Koralnik.   

Abstract

The cellullar immune response is important in the containment of progressive multifocal leukoencephalopathy (PML). We examined program cell death-1 (PD-1) expression, a marker of cellular immune exhaustion, on T lymphocytes in PML. PD-1 expression was elevated on total CD4(+) and CD8(+) T cells (medians 36% and 24%) in PML patients compared with healthy control subjects (medians 14% and 18%; P = 0.0015 and P = 0.033). In PML patients, JC virus (JCV)-specific CD8(+) cytotoxic T lymphocytes expressed PD-1 more frequently than total CD8 T lymphocytes (means 39% and 78%, P = 0.0004). Blocking the PD-1 receptor increased JCV-specific T-cell immune response in a subgroup of PML patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22549384      PMCID: PMC3400136          DOI: 10.1097/QAI.0b013e31825a313c

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  17 in total

Review 1.  Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

Authors:  Lieping Chen
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

2.  PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors.

Authors:  Ji-Yuan Zhang; Zheng Zhang; Xicheng Wang; Jun-Liang Fu; Jinxia Yao; Yanmei Jiao; Liangen Chen; Hui Zhang; Jianan Wei; Lei Jin; Ming Shi; George Fu Gao; Hao Wu; Fu-Sheng Wang
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

3.  Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy.

Authors:  T Weber; C Trebst; S Frye; P Cinque; L Vago; C J Sindic; W J Schulz-Schaeffer; H A Kretzschmar; W Enzensberger; G Hunsmann; W Lüke
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

4.  Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review.

Authors:  C K Petito; E S Cho; W Lemann; B A Navia; R W Price
Journal:  J Neuropathol Exp Neurol       Date:  1986-11       Impact factor: 3.685

5.  Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.

Authors:  Henry Radziewicz; Chris C Ibegbu; Marina L Fernandez; Kimberly A Workowski; Kamil Obideen; Mohammad Wehbi; Holly L Hanson; James P Steinberg; David Masopust; E John Wherry; John D Altman; Barry T Rouse; Gordon J Freeman; Rafi Ahmed; Arash Grakoui
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

7.  Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.

Authors:  Sarah Gheuens; Evelyn Bord; Santosh Kesari; David M Simpson; Rajesh T Gandhi; David B Clifford; Joseph R Berger; Long Ngo; Igor J Koralnik
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

8.  Progressive multifocal leukoencephalopathy in patients with HIV infection.

Authors:  J R Berger; L Pall; D Lanska; M Whiteman
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

9.  Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland.

Authors:  W Lang; J Miklossy; J P Deruaz; G P Pizzolato; A Probst; T Schaffner; E Gessaga; P Kleihues
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy.

Authors:  Angela Marzocchetti; Marco Lima; Troy Tompkins; Daniel G Kavanagh; Rajesh T Gandhi; David W O'Neill; Nina Bhardwaj; Igor J Koralnik
Journal:  Virology       Date:  2008-12-05       Impact factor: 3.616

View more
  32 in total

Review 1.  Immunology of progressive multifocal leukoencephalopathy.

Authors:  Ivan Jelcic; Ilijas Jelcic; Wolfgang Faigle; Mireia Sospedra; Roland Martin
Journal:  J Neurovirol       Date:  2015-03-05       Impact factor: 2.643

2.  PD-1 inhibition: a novel approach to the treatment of progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Ann Transl Med       Date:  2019-12

3.  Use of check-point inhibitors in the treatment of progressive multifocal leukoencephalopathy.

Authors:  Luis Miguel Juárez-Salcedo; Samir Dalia
Journal:  Ann Transl Med       Date:  2019-12

4.  Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?

Authors:  Daniele Focosi; Marco Tuccori; Fabrizio Maggi
Journal:  Ann Transl Med       Date:  2019-12

Review 5.  Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.

Authors:  S A Misbah
Journal:  Clin Exp Immunol       Date:  2017-03-27       Impact factor: 4.330

6.  Progressive multifocal leukoencephalopathy treated with nivolumab.

Authors:  Ethan Hoang; Nancy L Bartlett; Manu S Goyal; Robert E Schmidt; David B Clifford
Journal:  J Neurovirol       Date:  2019-03-12       Impact factor: 2.643

Review 7.  Immune surveillance and response to JC virus infection and PML.

Authors:  Sarah Beltrami; Jennifer Gordon
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

Review 8.  Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature.

Authors:  Christa S Zerbe; Beatriz E Marciano; Rohit K Katial; Carah B Santos; Nick Adamo; Amy P Hsu; Mary E Hanks; Dirk N Darnell; Martha M Quezado; Cathleen Frein; Lisa A Barnhart; Victoria L Anderson; Gulbu Uzel; Alexandra F Freeman; Andrea Lisco; Avindra Nath; Eugene O Major; Elizabeth P Sampaio; Steven M Holland
Journal:  Clin Infect Dis       Date:  2016-01-06       Impact factor: 9.079

Review 9.  Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration.

Authors:  S Richard Dunham; Robert Schmidt; David B Clifford
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

10.  Detection of JC virus-specific immune responses in a novel humanized mouse model.

Authors:  Chen Sabrina Tan; Thomas A Broge; Edward Seung; Vlad Vrbanac; Raphael Viscidi; Jennifer Gordon; Andrew M Tager; Igor J Koralnik
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.